Sveriges mest populära poddar
Research To Practice | Oncology Videos
Hälsa och motionMedicin

Acute Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia

1 tim 59 min•7 januari 2025

Featuring perspectives from Dr Alexander Perl, Dr Eytan M Stein, Dr Richard M Stone, Dr Eunice S Wang and Prof Andrew H Wei, moderated by Dr Stein, including the following topics:

  • Introduction (0:00)
  • Treatment for Older Patients with Acute Myeloid Leukemia (AML) — Prof Wei (2:48)
  • Selection of Initial Therapy for Younger Patients with AML without a Targetable Mutation, Including Those with Secondary AML — Dr Stone (26:52)
  • Role of FLT3 Inhibitors in AML Management — Dr Perl (49:41)
  • Incorporation of IDH Inhibitors into the Care of Patients with AML — Dr Stein (1:13:57)
  • Potential Role of Menin Inhibitors and Other Novel Agents in the Treatment of AML — Dr Wang (1:35:50)

CME information and select publications

Fler avsnitt av Research To Practice | Oncology Videos

Visa alla avsnitt av Research To Practice | Oncology Videos
Oral SERDs for Breast Cancer | Erica Mayer, MD, MPH, FASCO
•29 min
Oral SERDs for Breast Cancer | Aditya Bardia, MD, MPH
•28 min
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
•57 min
EGFR-Mutant Non-Small Cell Lung Cancer | Suresh S Ramalingam, MD
•26 min
EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD
•30 min
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
•17 min
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
•58 min
Prostate Cancer | Scott T Tagawa, MD, MS
•25 min
Prostate Cancer | Andrew J Armstrong, MD, ScM
•24 min
Menin Inhibitors in Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
•59 min

Research To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.